|
ADNP expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.257400E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.799840E-03 |
| Normal-vs-Stage2 |
1.875820E-01 |
| Normal-vs-Stage3 |
3.588200E-01 |
| Normal-vs-Stage4 |
2.738800E-01 |
| Stage1-vs-Stage2 |
6.905000E-01 |
| Stage1-vs-Stage3 |
4.012800E-01 |
| Stage1-vs-Stage4 |
7.913000E-01 |
| Stage2-vs-Stage3 |
7.773800E-01 |
| Stage2-vs-Stage4 |
9.752000E-01 |
| Stage3-vs-Stage4 |
7.998800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.724420E-02 |
| Normal-vs-AfricanAmerican |
9.921000E-03 |
| Normal-vs-Asian |
1.057600E-02 |
| Caucasian-vs-AfricanAmerican |
4.977000E-01 |
| Caucasian-vs-Asian |
1.217400E-01 |
| AfricanAmerican-vs-Asian |
3.698800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.046100E-04 |
| Normal-vs-Female |
8.656000E-01 |
| Male-vs-Female |
7.702400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.282300E-02 |
| Normal-vs-Extreme_Weight |
2.169300E-04 |
| Normal-vs-Obese |
3.903000E-01 |
| Normal-vs-Extreme_Obese |
5.579400E-04 |
| Normal_Weight-vs-Extreme_Weight |
4.450200E-01 |
| Normal_Weight-vs-Obese |
1.700570E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.092000E-01 |
| Extreme_Weight-vs-Obese |
1.564480E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.626800E-01 |
| Obese-vs-Extreme_Obese |
6.431500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.870000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.706600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.960210E-04 |
| Normal-vs-Age(81-100Yrs) |
6.08429999999771E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.627400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.532200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.537400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.404200E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.873500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.393000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.818300E-03 |
| Normal-VS-Type2 PRCC |
1.609350E-04 |
| Normal-VS-KIRP CIMP |
8.695000E-01 |
| Normal-VS-Unclassified PRCC |
6.041000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.177160E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.890000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.950400E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.129030E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.170020E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.939800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.009260E-04 |
| Normal-vs-N1 |
5.364600E-01 |
| Normal-vs-N2 |
3.757800E-02 |
| N0-vs-N1 |
1.777170E-03 |
| N0-vs-N2 |
9.692400E-01 |
| N1-vs-N2 |
2.195400E-01 |
|
|
